Rétine

• Vendredi, 1045-1215 Diabetes, central serous retinopathy, retinopathy of prematurity, occupational health
• Vendredi, 1330-1500 SCO-7 Mise à jour clinique : Rétine
• Samedi, 1045-1215 Retina AMD
• Samedi, 1330-1500 Imagerie de la rétine, les tumeurs et perte de vision par causes maculaires

Diabetes, central serous retinopathy, retinopathy of prematurity, occupational health

Le vendredi 6 juin
1045-1215
Pièce : 200 E

Objectifs
À la fin de la session, les participants pourront :

À venir

Horaire et description

1045	Introduction
1050	Controversies in the management of wet AMD Marco Zarbin
1120	Discussion
1130	Prevalence, severity and predictors of diabetic retinopathy among First Nations people in northern BC Lisa Weger, Peggy Yen, Andrew Jin, David Maberley
1125	Discussion
1127	Canadian assessment of real-world efficacy and safety of dexamethasone intravitreal implant in patients with DME Tom Sheidow, Wai-Ching Lam, Darryl Baptiste, Hany Phillips
1132	Discussion
1134	Bevacizumab vs. laser for the treatment of ROP. Comparison of visual function, structural outcomes and frequency of follow-up Nasrin N. Tehrani, Maram Isaac, Kamiar Mireskandari
1139	Discussion
1141	Oral mineralocorticoid antagonists for the treatment of central serous chorioretinopathy David R. Almeida, Eric Chin, James C. Folk, Stephen R. Russell
1146	Discussion
1148	Intravitreal anti-VEGF in the treatment of chronic central serous chorioretinopathy. A systematic review of the literature Haley Augustine, Monique Munro, Feisal Adatia
1153	Discussion
1155	Effects of hazardous ocular laser exposure in commercial airline pilots. A retrospective chart review Mathew Palakkamanil, Michael Fielden
1200	Review and open discussion

SCO-7 Mise à jour clinique : Rétine

Le vendredi 6 juin
1330-1500
Pièce : 200 CD

Objectifs
À la fin de la session, les participants pourront :

• Passer en revue les complications et la prise en charge de la cataracte
• Faire le point sur l’imagerie de la rétine
• Discuter de l’influence des antibiotiques sur l’endophtalmie après une injection intravitréenne

Horaire et description

1330	Introduction
1335	Update on the management of retinal venous occlusive diseaseSrinivas Sadda
1350	Discussion
1355	Management of endophthalmitis after ocular trauma Marco Zarbin
1410	Discussion
1415	Dislocated IOL repair Brandon Ayres
1430	Discussion
1435	Endophthalmitis after intraocular injections - Where are we? Peter Barry
1445	Infection after intravitreal injection: avoidance and management Terry O'Brien
1455	Discussion

Retina AMD

Le samedi 7 juin
1045-1215
Pièce : 303

Objectifs
À la fin de la session, les participants pourront :

• Faire le point sur les percées en matière d’imagerie de la DMLA
• Reconnaître les caractéristiques des images de la DMLA qui exigent une intervention précoce
• Passer en revue les plans de traitement de la DMLA exsudative et les résultats escomptés

Horaire et description

1045	Introduction
1050	Insights into the pathogenesis of AMD revealed by OCT Srinivas Sadda
1120	Discussion
1125	Prospective evaluation of tele-ophthalmology in initial screening for suspected exudative AMD Bo Li, Anne Marie Powell, Philip Hooper, Tom Sheidow
1130	Discussion
1132	An analysis of SD-OCT features that influence conversion to neovascular AMD in high-risk patients Gary Yau, Lisa Jagan, Sanjay Sharma
1137	Discussion
1139	Retrospective review of Lucentis "treat and extend" patterns and outcomes in AMD Tom Sheidow, Yufeng Chen, Alex Mao, Anne Marie Powell
1144	Discussion
1146	OCT-based predictions of geographic atrophy development in AMD Nawaaz A. Nathoo, Chris Or, Mei Young, Lica Chui, Nader Fallah, Andrew Kirker, David A. Albiani, Andrew B. Merkur, Farzin Forooghian
1151	Discussion
1153	Inhibition of the innate immune response with TMi-018 reduces the development of RPE loss in a model of dry AMD Shelley R. Boyd, Xu Zhao, David S. Baek, Natalie Pankova, Hai Wang
1158	Open discussion

Imagerie de la rétine, les tumeurs et perte de vision par causes maculaires

Le samedi 7 juin
1330-1500
Pièce : 303

Objectifs
À la fin de la session, les participants pourront :

À venir

Horaire et description

1330	Introduction
1333	What's next in OCT Srinivas Sadda
1348	Discussion
1352	Predictive value of peripheral non-perfusion in retinal venous occlusive disease Srinivas Sadda
1407	Discussion
1411	Structural abnormalities of the macula as causes of decreased vision post-successful primary retinal detachment repair Alice Y. Zhang, Sulaiman Al-Humaid, Christina Ryu, Michael A. Kapusta, John Galic, John C. Chen
1416	Discussion
1418	Delivery recommendations for healthy pregnant women with risk factors for rhegmatogenous retinal detachment. Current practice among Canadian ophthalmologists and obstetricians Hannah Chiu, Donna Steele, Chryssa McAlister, Wai-Ching Lam
1423	Discussion
1425	Predictive factors for the spontaneous resolution of vitreomacular traction David R. Almeida, Eric Chin, James C. Folk, Karim Rahim, Stephen R. Russell
1430	Discussion
1432	Clinical guidelines for idiopathic epiretinal membranes: a systematic review of the literature and survey of current practice Myra C. Butler, David Maberley
1437	Discussion
1439	Test characteristics of point-of-care ultrasonography for the diagnosis of acute posterior ocular pathology David M. Stitt, Michael Woo, Nathan Hecht, Bernard Hurley, Paul Pageau, Jame Worrall, Mark Reardon, Mark Taylor, Venkatash Thiruganasambandamoorthy
1451	Discussion
1446	Treatment of tumour margin recurrence of choroidal melanoma post-125-iodine brachytherapy with transpupillary thermotherapy Salah Alrashidi, E. Rand Simpson, Hatem Krema
1451	Discussion
1453	Zostavax-induced acute retinal necrosis Jeremy A. Murphy, Andrew Boswall, Christopher Seamone
1458	Discussion